3644 results for «2818»
3644 results
Publishing in interventional cardiology: aligning authors, editors and impact
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.
Beyond the diagnosis: a qualitative exploration of women’s experiences with cardiovascular disease
21 May 2026 – From EuroPCR 2026
This session presents a qualitative exploration of women's experiences with cardiovascular disease, highlighting unique challenges throughout their care pathway from diagnosis to rehabilitation. It shares robust patient experience data and offers recommendations aimed at improving cardiovascular care tailored to women’s specific needs.
Precision TAVI - Seering marginal gains
21 May 2026 – From EuroPCR 2026
This session delves into precision techniques in transcatheter aortic valve implantation (TAVI), highlighting novel stepwise implantation methods for self-expanding valves, the effects of internal diameter and valve fracture on gradients post valve-in-valve TAVI, and comparative analyses of implantation-depth variability across large-size TAVI platforms. Additionally, it evaluates...
TAVI procedural complications - Part 8: aortic dissection, multiple valves procedures, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications encountered during TAVI, featuring challenging cases such as aortic dissection, multiple valve procedures including redo TAVI in patients with left ventricular assist devices, and structural failures like valve infolding and embolisation. It emphasizes strategic decision-making under critical circumstances to optimize...
Risk and prognosis predictors in STEMI
21 May 2026 – From EuroPCR 2026
This session explores key risk and prognostic factors in ST-elevation myocardial infarction (STEMI), encompassing biomarker-based outcome prediction, the influence of low-density lipoprotein cholesterol on myocardial injury, and thrombotic risk in atrial fibrillation patients undergoing PCI. It further examines gender differences in young STEMI patients, the safety...
Primary PCI dilemmas: when imaging saves the day
21 May 2026 – From EuroPCR 2026
This session highlights the pivotal role of imaging in resolving dilemmas during primary percutaneous coronary intervention (PCI). It presents complex cases illustrating challenges such as coronary compression, thrombus burden in large vessels, and culprit lesion identification, including the use of high-definition intravascular ultrasound (HD-IVUS) to reclassify...
Haemodynamic support: from shock to complex high-risk interventional problems
21 May 2026 – From EuroPCR 2026
This session examines haemodynamic support from cardiogenic shock through to complex high-risk interventional cardiology procedures. It features registry data, clinical outcomes, and procedural techniques including mechanical circulatory support and arterial access strategies.
Overcoming complications with intracoronary imaging
21 May 2026 – From EuroPCR 2026
Explore challenging cases of intracoronary imaging complications, highlighting recognition, management, and resolution of complex vascular and mechanical issues encountered during coronary interventions.
Percutaneous management of mitral and aortic valve disease
21 May 2026 – From EuroPCR 2026
Delve into the percutaneous management of mitral and aortic valve disease through detailed procedural demonstrations. This session covers valve-in-valve procedures, navigation of potential complications in valve-in-valve TAVI, and mitral valve edge-to-edge repair techniques, supported by real-world case discussions and key learnings.
Refining management of NSTEMI
21 May 2026 – From EuroPCR 2026
This session refines NSTEMI management by exploring advanced diagnostic tools, risk stratification, and tailored revascularization strategies, including bleeding risk assessment and dual antiplatelet therapy considerations.
Complex multivessel disease: from calcium to physiology - Case-based decisions
21 May 2026 – From EuroPCR 2026
Focus on complex multivessel coronary artery disease management with an emphasis on severely calcified lesions and the integration of intracoronary imaging and physiology. This session prepares clinicians to anticipate and manage complications during PCI, enhancing competence in treating challenging coronary anatomies through case-based decision-making.
Aneurysms and fistulas: contemporary approaches
21 May 2026 – From EuroPCR 2026
Focus on contemporary approaches to coronary aneurysms and fistulas, presenting complex interventional techniques and case-based strategies to overcome anatomical challenges and ensure effective treatment.
How to achieve coronary patency during TAVI
21 May 2026 – From EuroPCR 2026
This session addresses techniques to achieve coronary artery patency during transcatheter aortic valve implantation (TAVI), highlighting advanced procedural approaches and management of high-risk anatomical scenarios.
Insight from new evidence for complex PCI: value of imaging (CHIP IVUS) and left ventricular support (CHIP BCIS 3)
21 May 2026 – From EuroPCR 2026
This session reviews the impact of recent evidence on complex PCI, highlighting the value of intracoronary imaging (CHIP IVUS trial) and left ventricular assist devices (CHIP BCIS 3 trial). Through case discussions, participants reflect on how these innovations influence daily clinical practice and enhance procedural planning...
Sealing the deal: catheter based solutions for aortic disease
21 May 2026 – From EuroPCR 2026
Examine catheter-based solutions for aortic disease management, featuring innovative approaches to preserving branch vessels, managing vascular complications, and repairing challenging aneurysms with endografts and occluders.
CTO PCI: an evolving landscape
21 May 2026 – From EuroPCR 2026
Review the evolving landscape of chronic total occlusion (CTO) PCI with a focus on recent trends, contemporary management in multivessel disease, and innovative techniques such as retrograde approaches and titrated contrast recanalization. This session also addresses cost-effectiveness and drug-coated balloon (DCB) therapy outcomes from multicenter studies.
Various NSTEMI cases
21 May 2026 – From EuroPCR 2026
This session presents diverse NSTEMI case studies addressing complex diagnostic and interventional challenges, including coronary dissections, intramural hematomas, ischemic complications, and functional lesion assessment.
CTO ADVANCED Level II: LIVE Educational Cases from Cleveland Clinic London, UK & University Hospital Basel, Switzerland
21 May 2026 – From EuroPCR 2026
This advanced session presents live educational cases on chronic total occlusions (CTO) from leading centers in London and Basel. Participants gain insights into selecting antegrade versus retrograde approaches, interpreting intravascular imaging for informed decision-making, and integrating sophisticated tools and techniques to enhance procedural success in complex...
Left main complications - Part 3
21 May 2026 – From EuroPCR 2026
This session reviews complex complications encountered in left main coronary interventions. It covers causes and management of acute left main occlusion, critical stenosis of coronary buttons, retrieval techniques for ostial stents, and strategies for managing challenging PCI scenarios that may precipitate or resolve catastrophic events.
Multivessel disease or left main disease
22 May 2026 – From EuroPCR 2026
This session explores revascularisation strategies for patients with multivessel or left main coronary artery disease. It emphasizes the role of intravascular physiology and imaging in guiding treatment decisions and highlights procedural factors that contribute to improved long-term clinical outcomes, supported by complex case discussions.